EDGAR Filing Agent Form List
CIK: 0001943462
Form Type:
Year
| Form | Filer/Owner | Description | Subject Company | Date | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G/A | Tenax Therapeutics, Inc. | 04/04/2025 | |||
| SCHEDULE 13G/A | Tenax Therapeutics, Inc. | 01/15/2025 | |||
| 3 | Dellora Investments Lp | Initial statement of beneficial ownership of securities | Tenax Therapeutics, Inc. | 01/10/2025 | |
| SCHEDULE 13G/A | Palvella Therapeutics, Inc. | 12/17/2024 | |||
| 4 | Dellora Investments Lp | Statement of changes in beneficial ownership of securi... | Palvella Therapeutics, Inc. | 12/16/2024 | |
| SCHEDULE 13G/A | Pieris Pharmaceuticals, Inc. | 12/06/2024 | |||
| SCHEDULE 13G | Tenax Therapeutics, Inc. | 12/05/2024 | |||
| 3 | Dellora Investments Lp | Initial statement of beneficial ownership of securities | Pieris Pharmaceuticals, Inc. | 11/18/2024 | |
| SCHEDULE 13G | Pieris Pharmaceuticals, Inc. | 08/07/2024 | |||
| SC 13G/A | Dellora Investments Lp | Amendment to Schedule filed to report acquisition of b... | Cyclacel Pharmaceuticals, Inc. | 02/14/2024 | |
| Load More | |||||
